查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1888690

血液黏度计市场规模、份额和趋势分析报告：按产品、应用、最终用途、地区和细分市场预测（2025-2033 年）

Blood Viscometer Market Size, Share & Trends Analysis Report By Product, By Application (Clinical Diagnostics, Point-of-Care Testing ), By End Use, By Region, And Segment Forecasts, 2025 - 2033
出版日期: | 出版商: Grand View Research | 英文 105 Pages | 商品交期: 2-10个工作天内

价格

血液黏度计市场摘要

2024年全球血液黏度计市场规模估计为16.2亿美元，预计到2033年将达到26.3亿美元。

预计从 2025 年到 2033 年，该行业将以 5.63% 的复合年增长率成长。临床诊断技术的进步、心血管和血液疾病盛行率的增加以及就地检验技术的日益普及都支撑了这一增长前景。

2023年4月发表于《临床血液流变学与微循环》杂誌的一项研究探讨了冠状动脉疾病患者的血液流变学和一氧化氮（NO）水平。结果表明，红血球聚集度高和NO水平低与心臟侧支循环发育不良有关。血液黏度测量技术不断创新，最新设备能够实现即时测量，所需检体量极少，且对非牛顿流体的灵敏度更高。这些进步使得流变学评估更加精确，提高了糖尿病、高黏滞性症候群和血栓症等疾病的诊断准确性，并扩大了其在常规临床检测中的应用。 2022年12月发表于《生物医学日誌》的一篇论文探讨了接地（与地球表面直接接触）如何帮助减轻发炎、稳定心率和改善血流。该研究证实了ZETA电位的可测量改善，显示红血球聚集减少。 zeta电位与黏度直接相关，因此在临床研究中对其进行监测至关重要。

心血管疾病、贫血和凝血障碍发病率的上升推动了对精确黏度测量工具的需求。这些疾病通常伴随血流特性的改变，因此黏度计在患者风险评估、治疗后续观察和治疗方法优化中的应用日益广泛。 2025年2月，世界卫生组织（WHO）报告称，全球40%的婴儿、37%的孕妇和30%的育龄妇女患有贫血。

朝向分散式和快速诊断解决方案的转变，推动了对紧凑、易用型黏度计的需求，这类黏度计可在加护病房(ICU) 和门诊等医疗点提供即时结果。这一趋势有助于疾病的早期发现，并促进符合个人化医疗理念的、经济高效的医疗保健服务，从而维持市场成长。 2023 年 10 月发表在《应用物理学杂誌》上的一项研究介绍了一种磁性落球粘度计，该粘度计利用磁化球和磁通门磁力计来追踪其在流体中的运动。此系统仅需 15 毫升样品，即可在数秒内测量 200-3000 cP 范围内的黏度，精度可达 3%。

目录

第一章调查方法和范围

第二章执行摘要

第三章 血液黏度计市场变数、趋势与范围

  • 市场谱系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
  • 血液黏度计市场分析工具
    • 产业分析 - 波特五力
    • PESTEL 分析
  • 科技趋势
  • 法律规范
  • 案例研究分析

第四章 血液黏度计市场：依产品分類的估算与趋势分析

  • 定义和范围
  • 按产品分類的市占率分析（2024 年和 2033 年）
  • 毛细管黏度计
  • 旋转黏度计
  • 振动/振盪黏度计
  • 微流体黏度计

第五章 血液黏度计市场：按应用分類的估算与趋势分析

  • 定义和范围
  • 按应用领域分類的市场份额分析（2024 年和 2033 年）
  • 临床诊断
  • 血液学和血液检查
  • 就地检验（POC​​T）

第六章：血液黏度计市场：依最终用途分類的估算与趋势分析

  • 定义和范围
  • 按最终用途分類的市场份额分析（2024 年和 2033 年）
  • 医院和诊断检查室
  • 研究和学术机构
  • 製药和生物技术公司

第七章 血液黏度计市场：区域估算与趋势分析

  • 区域仪錶板
  • 市场规模、预测与趋势分析（2021-2033）
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争情势

  • 公司/竞争对手分类
  • 供应商概况
    • 主要企业市占率分析，2024 年
    • Anton Paar GmbH
    • RheoSense, Inc.
    • Benson Viscometers-Clinical Viscometers
    • Beijing Steellex Scientific Instrument Co., Ltd.
    • Health Onvector
    • KYOTO ELECTRONICS MANUFACTURING CO., LTD.
    • A&D;Company, Limited
    • AMETEK.Inc.
    • Cannon Instrument Company.
    • CSC Scientific Company, Inc.
Product Code: GVR-4-68040-818-2

Blood Viscometer Market Summary

The global blood viscometer market size was estimated at USD 1.62 billion in 2024 and is projected to reach USD 2.63 billion by 2033, growing at a CAGR of 5.63% from 2025 to 2033. The growth outlook by advancements in clinical diagnostics, the increasing prevalence of cardiovascular and hematological disorders, and the growing adoption of point-of-care testing technologies.

In April 2023, a study published in Clinical Hemorheology and Microcirculation examined blood rheology and nitric oxide levels in coronary artery disease patients. The findings showed that higher erythrocyte aggregation and lower NO levels were linked to poorer collateral vessel development in the heart. Innovation in blood viscometry is increasing, with modern instruments offering real-time measurement, minimal sample volume requirements, and enhanced sensitivity for non-Newtonian fluids. These advancements enable more precise rheology assessments, improve diagnostic accuracy in conditions such as diabetes, hyperviscosity syndromes, and thrombosis, and expand use in routine clinical testing.In December 2022, an article in the Biomedical Journal discussed how grounding, or direct contact with the Earth's surface, helps lower inflammation, stabilize heart rate, and improve flow. The study noted measurable improvements in zeta potential, suggesting reduced red blood cell aggregation, a factor directly linked to viscosity and its monitoring in clinical research.

The rising incidence of cardiovascular diseases, anemia, and coagulation disorders is fueling demand for accurate viscosity measurement tools. As these disorders often involve changes in blood flow properties, viscometers are increasingly used for patient risk assessment, treatment monitoring, and therapy optimization.In February 2025, the World Health Organization (WHO) reported that anemia affects 40% of young children, 37% of pregnant women, and 30% of women of reproductive age worldwide.

The shift toward decentralized, rapid diagnostic solutions is driving demand for compact, user-friendly viscometers that deliver instant results in point-of-care settings, such as ICUs and outpatient clinics. This trend supports early disease detection, aligns with personalized medicine, and promotes cost-efficient healthcare delivery, sustaining market growth. In October 2023, a study in the Journal of Applied Physics presented a magnetic falling-sphere viscometer that employs a magnetized sphere and fluxgate magnetometers to track its motion through fluid. The system requires only 15 ml of sample and determines viscosities from 200 to 3000 cP within seconds, achieving 3% precision.

Global Blood Viscometer Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global blood viscometer market report based on product, application, end use, and region.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Capillary Viscometer
  • Rotational Viscometer
  • Vibrational / Oscillatory Viscometer
  • Microfluidic Viscometer
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Clinical Diagnostics
  • Hematology & Blood Research
  • Point-of-Care Testing (POCT)
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Diagnostic Laboratories
  • Research & Academic Institutes
  • Pharmaceutical & Biotechnology Companies
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa (MEA)
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Blood Viscometer Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Rising prevalence of cardiovascular and metabolic disorders
      • 3.2.1.2. Shift toward advanced point-of-care and research diagnostics
      • 3.2.1.3. Healthcare infrastructure expansion and private lab proliferation
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. High device cost and limited reimbursement support
      • 3.2.2.2. Lack of technical expertise and standardized protocols
    • 3.2.3. Competitive factors and strategies
      • 3.2.3.1. Clinical insights
      • 3.2.3.2. Emerging technologies
      • 3.2.3.3. Market appeal
      • 3.2.3.4. Product improvements and innovations
  • 3.3. Blood Viscometer Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. Technology landscape
  • 3.5. Regulatory Framework
  • 3.6. Case Study Analysis

Chapter 4. Blood Viscometer Market: Product Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Product Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Capillary Viscometer
    • 4.4.1. Capillary viscometer market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.5. Rotational Viscometer
    • 4.5.1. Rotational viscometer market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.6. Vibrational / Oscillatory Viscometer
    • 4.6.1. Vibrational / oscillatory viscometer market estimates and forecasts 2021 to 2033 (USD Million)
  • 4.7. Microfluidic Viscometer
    • 4.7.1. Microfluidic viscometer market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 5. Blood Viscometer Market: Application Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Application Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Clinical Diagnostics
    • 5.4.1. Clinical diagnostics market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.5. Hematology & Blood Research
    • 5.5.1. Hematology & blood research market estimates and forecasts 2021 to 2033 (USD Million)
  • 5.6. Point-of-Care Testing (POCT)
    • 5.6.1. Point-of-care testing (POCT) market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 6. Blood Viscometer Market: End Use Estimates & Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. End Use Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Hospitals & Diagnostic Laboratories
    • 6.4.1. Hospitals & diagnostic laboratories market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.5. Research & Academic Institutes
    • 6.5.1. Research & academic institutes market estimates and forecasts 2021 to 2033 (USD Million)
  • 6.6. Pharmaceutical & Biotechnology Companies
    • 6.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 7. Blood Viscometer Market: Regional Estimates & Trend Analysis by Product, Application and End Use

  • 7.1. Regional Dashboard
  • 7.2. Market Size, & Forecasts Trend Analysis, 2021 to 2033:
  • 7.3. North America
    • 7.3.1. U.S.
      • 7.3.1.1. Key country dynamics
      • 7.3.1.2. Regulatory framework/ reimbursement structure
      • 7.3.1.3. Competitive scenario
      • 7.3.1.4. U.S. market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.2. Canada
      • 7.3.2.1. Key country dynamics
      • 7.3.2.2. Regulatory framework/ reimbursement structure
      • 7.3.2.3. Competitive scenario
      • 7.3.2.4. Canada market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.3.3. Mexico
      • 7.3.3.1. Key country dynamics
      • 7.3.3.2. Regulatory framework/ reimbursement structure
      • 7.3.3.3. Competitive scenario
      • 7.3.3.4. Mexico market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Key country dynamics
      • 7.4.1.2. Regulatory framework/ reimbursement structure
      • 7.4.1.3. Competitive scenario
      • 7.4.1.4. UK market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Key country dynamics
      • 7.4.2.2. Regulatory framework/ reimbursement structure
      • 7.4.2.3. Competitive scenario
      • 7.4.2.4. Germany market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.3. France
      • 7.4.3.1. Key country dynamics
      • 7.4.3.2. Regulatory framework/ reimbursement structure
      • 7.4.3.3. Competitive scenario
      • 7.4.3.4. France market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Key country dynamics
      • 7.4.4.2. Regulatory framework/ reimbursement structure
      • 7.4.4.3. Competitive scenario
      • 7.4.4.4. Italy market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Key country dynamics
      • 7.4.5.2. Regulatory framework/ reimbursement structure
      • 7.4.5.3. Competitive scenario
      • 7.4.5.4. Spain market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.6. Norway
      • 7.4.6.1. Key country dynamics
      • 7.4.6.2. Regulatory framework/ reimbursement structure
      • 7.4.6.3. Competitive scenario
      • 7.4.6.4. Norway market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Key country dynamics
      • 7.4.7.2. Regulatory framework/ reimbursement structure
      • 7.4.7.3. Competitive scenario
      • 7.4.7.4. Sweden market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.4.8. Denmark
      • 7.4.8.1. Key country dynamics
      • 7.4.8.2. Regulatory framework/ reimbursement structure
      • 7.4.8.3. Competitive scenario
      • 7.4.8.4. Denmark market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/ reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. Japan market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.2. China
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/ reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. China market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.3. India
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Regulatory framework/ reimbursement structure
      • 7.5.3.3. Competitive scenario
      • 7.5.3.4. India market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Key country dynamics
      • 7.5.4.2. Regulatory framework/ reimbursement structure
      • 7.5.4.3. Competitive scenario
      • 7.5.4.4. Australia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.5. South Korea
      • 7.5.5.1. Key country dynamics
      • 7.5.5.2. Regulatory framework/ reimbursement structure
      • 7.5.5.3. Competitive scenario
      • 7.5.5.4. South Korea market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.5.6. Thailand
      • 7.5.6.1. Key country dynamics
      • 7.5.6.2. Regulatory framework/ reimbursement structure
      • 7.5.6.3. Competitive scenario
      • 7.5.6.4. Thailand market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/ reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. Brazil market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.6.2. Argentina
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/ reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Argentina market estimates and forecasts 2021 to 2033 (USD Million)
  • 7.7. Middle East & Africa
    • 7.7.1. South Africa
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/ reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. South Africa market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/ reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/ reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. UAE market estimates and forecasts 2021 to 2033 (USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/ reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Kuwait market estimates and forecasts 2021 to 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company/Competition Categorization
  • 8.2. Vendor Landscape
    • 8.2.1. Key company market share analysis, 2024
    • 8.2.2. Anton Paar GmbH
      • 8.2.2.1. Overview
      • 8.2.2.2. Financial Performance
      • 8.2.2.3. Product Benchmarking
      • 8.2.2.4. Strategic Initiatives
    • 8.2.3. RheoSense, Inc.
      • 8.2.3.1. Overview
      • 8.2.3.2. Financial Performance
      • 8.2.3.3. Product Benchmarking
      • 8.2.3.4. Strategic Initiatives
    • 8.2.4. Benson Viscometers - Clinical Viscometers
      • 8.2.4.1. Overview
      • 8.2.4.2. Financial Performance
      • 8.2.4.3. Product Benchmarking
      • 8.2.4.4. Strategic Initiatives
    • 8.2.5. Beijing Steellex Scientific Instrument Co., Ltd.
      • 8.2.5.1. Overview
      • 8.2.5.2. Financial Performance
      • 8.2.5.3. Product Benchmarking
      • 8.2.5.4. Strategic Initiatives
    • 8.2.6. Health Onvector
      • 8.2.6.1. Overview
      • 8.2.6.2. Financial Performance
      • 8.2.6.3. Product Benchmarking
      • 8.2.6.4. Strategic Initiatives
    • 8.2.7. KYOTO ELECTRONICS MANUFACTURING CO., LTD.
      • 8.2.7.1. Overview
      • 8.2.7.2. Financial Performance
      • 8.2.7.3. Product Benchmarking
      • 8.2.7.4. Strategic Initiatives
    • 8.2.8. A&D Company, Limited
      • 8.2.8.1. Overview
      • 8.2.8.2. Financial Performance
      • 8.2.8.3. Product Benchmarking
      • 8.2.8.4. Strategic Initiatives
    • 8.2.9. AMETEK.Inc.
      • 8.2.9.1. Overview
      • 8.2.9.2. Financial Performance
      • 8.2.9.3. Product Benchmarking
      • 8.2.9.4. Strategic Initiatives
    • 8.2.10. Cannon Instrument Company.
      • 8.2.10.1. Overview
      • 8.2.10.2. Financial Performance
      • 8.2.10.3. Product Benchmarking
      • 8.2.10.4. Strategic Initiatives
    • 8.2.11. CSC Scientific Company, Inc.
      • 8.2.11.1. Overview
      • 8.2.11.2. Financial Performance
      • 8.2.11.3. Product Benchmarking
      • 8.2.11.4. Strategic Initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America blood viscometer market, by region, 2021 - 2033 (USD Million)
  • Table 3 North America blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 4 North America blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 5 North America blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 6 U.S. blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 7 U.S. blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 8 U.S. blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 9 Canada blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 10 Canada blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 11 Canada blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 12 Mexico blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 13 Mexico blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 14 Mexico blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 15 Europe blood viscometer market, by region, 2021 - 2033 (USD Million)
  • Table 16 Europe blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 17 Europe blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 18 Europe blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 19 Germany blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 20 Germany blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 21 Germany blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 22 UK blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 23 UK blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 24 UK blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 25 France blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 26 France blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 27 France blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 28 Italy blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 29 Italy blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 30 Italy blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 31 Spain blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 32 Spain blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 33 Spain blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 34 Denmark blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 35 Denmark blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 36 Denmark blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 37 Sweden blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 38 Sweden blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 39 Sweden blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 40 Norway blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 41 Norway blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 42 Norway blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 43 Asia Pacific blood viscometer market, by region, 2021 - 2033 (USD Million)
  • Table 44 Asia Pacific blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 45 Asia Pacific blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 46 Asia Pacific blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 47 China blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 48 China blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 49 China blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 50 Japan blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 51 Japan blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 52 Japan blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 53 India blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 54 India blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 55 India blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 56 South Korea blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 57 South Korea blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 58 South Korea blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 59 Australia blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 60 Australia blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 61 Australia blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 62 Thailand blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 63 Thailand blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 64 Thailand blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 65 Latin America blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 66 Latin America blood viscometer market, by region, 2021 - 2033 (USD Million)
  • Table 67 Latin America blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 68 Latin America blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 69 Brazil blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 70 Brazil blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 71 Brazil blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 72 Argentina blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 73 Argentina blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 74 Argentina blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 75 Middle East and Africa blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 76 Middle East and Africa blood viscometer market, by region, 2021 - 2033 (USD Million)
  • Table 77 Middle East and Africa blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 78 Middle East and Africa blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 79 South Africa blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 80 South Africa blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 81 South Africa blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 82 Saudi Arabia blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 83 Saudi Arabia blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 84 Saudi Arabia blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 85 UAE blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 86 UAE blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 87 UAE blood viscometer market, by end use, 2021 - 2033 (USD Million)
  • Table 88 Kuwait blood viscometer market, by product, 2021 - 2033 (USD Million)
  • Table 89 Kuwait blood viscometer market, by application, 2021 - 2033 (USD Million)
  • Table 90 Kuwait blood viscometer market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 Value-chain-based sizing & forecasting
  • Fig. 6 QFD modeling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Blood viscometer market: outlook
  • Fig. 9 Blood viscometer competitive insights
  • Fig. 10 Ancillary market outlook
  • Fig. 11 Blood viscometer market driver impact
  • Fig. 12 Blood viscometer market restraint impact
  • Fig. 13 Porter's Analysis
  • Fig. 14 PESTLE Analysis
  • Fig. 15 Blood viscometer market: Product movement analysis
  • Fig. 16 Blood viscometer market: Product outlook and key takeaways
  • Fig. 17 Capillary viscometer market estimates and forecast, 2021 - 2033
  • Fig. 18 Rotational viscometer market estimates and forecast, 2021 - 2033
  • Fig. 19 Vibrational / oscillatory viscometer market estimates and forecast, 2021 - 2033
  • Fig. 20 Microfluidic viscometer market estimates and forecast, 2021 - 2033
  • Fig. 21 Blood viscometer market: Application movement analysis
  • Fig. 22 Blood viscometer market: Application outlook and key takeaways
  • Fig. 23 Clinical diagnostics market estimates and forecast, 2021 - 2033
  • Fig. 24 Hematology & blood research market estimates and forecast, 2021 - 2033
  • Fig. 25 Point-of-care testing (POCT) market estimates and forecast, 2021 - 2033
  • Fig. 26 Blood viscometer market: End use movement analysis
  • Fig. 27 Blood viscometer market: End use outlook and key takeaways
  • Fig. 28 Hospitals & diagnostic laboratories market estimates and forecast, 2021 - 2033
  • Fig. 29 Research & academic institutes market estimates and forecast, 2021 - 2033
  • Fig. 30 Pharmaceutical & biotechnology companies market estimates and forecast, 2021 - 2033
  • Fig. 31 Global blood viscometer market: Regional movement analysis
  • Fig. 32 Global blood viscometer market: Regional outlook and key takeaways
  • Fig. 33 North America, by country
  • Fig. 34 North America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 35 U.S. key country dynamics
  • Fig. 36 U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 37 Canada key country dynamics
  • Fig. 38 Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 39 Mexico key country dynamics
  • Fig. 40 Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 41 Europe market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 42 UK key country dynamics
  • Fig. 43 UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 44 Germany key country dynamics
  • Fig. 45 Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 46 France key country dynamics
  • Fig. 47 France market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 48 Italy key country dynamics
  • Fig. 49 Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 50 Spain key country dynamics
  • Fig. 51 Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 52 Denmark key country dynamics
  • Fig. 53 Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 54 Sweden key country dynamics
  • Fig. 55 Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 56 Norway key country dynamics
  • Fig. 57 Norway market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 58 Asia Pacific market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 59 China key country dynamics
  • Fig. 60 China market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 61 Japan key country dynamics
  • Fig. 62 Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 63 India key country dynamics
  • Fig. 64 India market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 65 Thailand key country dynamics
  • Fig. 66 Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 67 South Korea key country dynamics
  • Fig. 68 South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 69 Australia key country dynamics
  • Fig. 70 Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 71 Latin America market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 72 Brazil key country dynamics
  • Fig. 73 Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 74 Argentina key country dynamics
  • Fig. 75 Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 76 Middle East and Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 77 South Africa key country dynamics
  • Fig. 78 South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 79 Saudi Arabia key country dynamics
  • Fig. 80 Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 81 UAE key country dynamics
  • Fig. 82 UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 83 Kuwait key country dynamics
  • Fig. 84 Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 85 Key company categorization
  • Fig. 86 Heat map analysis 2024